Woodline Partners’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Buy |
+43,380
| New | +$1.36M | 0.01% | 774 |
|
|
2025
Q1 | – | Sell |
-39,938
| Closed | -$1.57M | – | 1052 |
|
|
2024
Q4 | $1.57M | Buy |
+39,938
| New | +$1.57M | 0.01% | 692 |
|
|
2024
Q1 | – | Sell |
-196,453
| Closed | -$9.05M | – | 646 |
|
|
2023
Q4 | $9.05M | Buy |
196,453
+53,002
| +37% | +$2.44M | 0.1% | 240 |
|
|
2023
Q3 | $4.9M | Sell |
143,451
-146,949
| -51% | -$5.02M | 0.06% | 312 |
|
|
2023
Q2 | $11.2M | Sell |
290,400
-129,629
| -31% | -$4.99M | 0.13% | 193 |
|
|
2023
Q1 | $15M | Buy |
420,029
+121,589
| +41% | +$4.35M | 0.2% | 140 |
|
|
2022
Q4 | $11.8M | Sell |
298,440
-105,919
| -26% | -$4.18M | 0.16% | 181 |
|
|
2022
Q3 | $14.6M | Buy |
404,359
+175,431
| +77% | +$6.33M | 0.2% | 146 |
|
|
2022
Q2 | $6.96M | Buy |
+228,928
| New | +$6.96M | 0.11% | 215 |
|
|
2021
Q4 | – | Sell |
-199,984
| Closed | -$3.06M | – | 797 |
|
|
2021
Q3 | $3.06M | Buy |
+199,984
| New | +$3.06M | 0.05% | 332 |
|